Published : 2021-03-23 - Duration : 03:25 - View : 9
Dailymotion : Download Convert to MP3
Description :
AstraZeneca-Oxford’s Covid-19 vaccine demonstrated an efficacy of 79% at preventing symptomatic Covid-19 in large-scale phase III trials in the US, much higher than UK trial results. Interim data rests speculation on the vaccine’s efficacy on those over 65 years, and showed a 100% efficacy against severe disease & hospitalisation. The data vali...

Related Videos :
Study Finds AstraZeneca Vaccine to Be 79 Percent Efficient Against Symptomatic COVID-19 Created : 22-03-2021 View : 63 |
COVID vaccine: 8 health conditions that reduces vaccine efficacy Created : 05-02-2022 View : 3 |
Controversy Over Bharat Biotech’s COVID-19 Vaccine; Health Minister & Opposition Leaders Spar Over Efficacy Created : 04-01-2021 View : 1 |